| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $20.1M | -45.5% |
| SG&A Expense | $19.0M | -9.5% |
| Operating Income | -$44.7M | +22.4% |
| Interest Expense | $2.5M | -31.1% |
| Net Income | -$39.9M | +33.5% |
| EPS (Basic) | -$2.70 | +57.2% |
| EPS (Diluted) | -$2.70 | +57.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.8M | +55.5% |
| Short-term Investments | $23.4M | -71.5% |
| Current Assets | $46.6M | -51.7% |
| Total Assets | $65.7M | -47.2% |
| Current Liabilities | $7.8M | -60.0% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities | $37.3M | -35.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$37.1M | +27.3% |
| Capital Expenditures | $11K | -88.5% |
| Investing Cash Flow | $60.5M | +346.5% |
| Financing Cash Flow | -$16.3M | -129.8% |
| Free Cash Flow | -$37.1M | +27.4% |
| Stockholders' Equity |
| $28.4M |
| -57.5% |